Latest Health News

Kingsgate Consolidated reports a strong FY25 at its Chatree Gold Mine with 75,000 ounces produced and sets ambitious FY26 targets, while advancing its Chilean project.

InFocus Group Holdings has locked in up to AUD 1.7 million in potential revenues through new contracts in healthcare and logistics, underpinning its operational expansion in Southeast Asia.

Light & Wonder, Inc. has announced a proposed $1 billion private offering of senior unsecured notes due 2033, aiming to refinance existing debt and support corporate initiatives.

Spenda Limited announces the resignation of CEO Adrian Floate due to health concerns, appointing COO Corrie Hassan as interim CEO and welcoming Francis DeSouza to the Board. The company aims to maintain momentum following a record revenue year.

LDR Assets, controlled by the Lederer Family Office, has made a $0.70 per security cash offer for Elanor Commercial Property Fund, representing a premium to recent trading prices and net tangible asset backing. The bid highlights concerns over ECF's financial performance and Elanor Investors Group's solvency risks, with plans to overhaul management post-acquisition.

Alternative Investment Trust (AIQ) has successfully completed a 1 for 1 non-renounceable rights issue, issuing over 23 million new units and significantly increasing its cash reserves.

BPH Global has completed an 18-week R&D collaboration with Singapore Polytechnic, developing two innovative green seaweed kefir beverages that combine health benefits with commercial promise.

Ramsay Health Care has clarified that its underlying earnings for FY25 aligned closely with market consensus, despite a significant non-cash impairment impacting statutory profits. The company confirms compliance with ASX disclosure rules amid share price volatility.

Pengana International Equities Limited has announced an on-market buy-back of up to 25.7 million ordinary shares, signaling a strategic capital management move without requiring shareholder approval.

Artrya Limited has raised A$75 million through a two-tranche placement and launched a A$5 million share purchase plan to fast-track the U.S. commercialisation of its AI-powered Salix platform following FDA clearance.

Computershare Limited has announced an ordinary dividend of AUD 0.48 per share for the half-year ending June 2025, alongside a confirmed Dividend Reinvestment Plan price of AUD 37.64.

Proteomics International Laboratories announces the planned retirement of its founder and Managing Director, Dr Richard Lipscombe, in February 2026, marking a pivotal leadership transition as the company seeks a new CEO to drive its next growth phase.